immunity · Mechanism Report
Can low vitamin D status and CYP2R1 rs10741657 AG affect autoimmune thyroid antibody activity?
Low vitamin D status, especially with the CYP2R1 rs10741657 AG genotype, may reduce vitamin D availability for immune tolerance and influence thyroid autoantibody activity.
This is what AI claimed
Low vitamin D status and CYP2R1 rs10741657 AG can reduce vitamin D availability for immune tolerance, which is relevant to autoimmune thyroid antibody activity.
Executive summary
The claim says that low vitamin D status together with the CYP2R1 rs10741657 AG genotype can limit the body’s circulating vitamin D pool. The mechanism frames this as reduced vitamin D conversion and weaker immune tolerance, which may create conditions linked to autoimmune thyroid antibody activity. Direct quantitative evidence for thyroid antibody levels is limited, but the pathway is presented as biologically plausible.
Verified conclusion
Low systemic vitamin D status, compounded by genetic variations in its metabolic pathways, plays an important role in immune function and autoimmunity.
Genetic and physiological mechanisms
- The CYP2R1 gene encodes the principal hepatic 25-hydroxylase enzyme responsible for converting dietary and synthesized vitamin D into its primary circulating form, 25-hydroxyvitamin D [25(OH)D].
- The rs10741657 AG genotype, which carries the risk-associated G-allele, is robustly linked to decreased CYP2R1 expression and reduced hepatic 25-hydroxylase activity.
- This genetic impairment, combined with a low baseline vitamin D status, directly restricts the systemic 25(OH)D pool available for downstream metabolic and immune pathways.
Immune tolerance and thyroid autoimmunity
- Active 1,25(OH)2D is a potent immunomodulator that maintains immune tolerance by regulating dendritic cells, promoting T-regulatory (Treg) cell differentiation, and modulating the inflammatory Th1/Th17 cytokine axis.
- Reduced circulating 25(OH)D levels limit the capacity of local immune cells to synthesize active 1,25(OH)2D via intracrine pathways, compromising immune tolerance and creating a pro-inflammatory state.
- While epidemiological evidence consistently connects vitamin D deficiency to autoimmune thyroid diseases, direct clinical evidence mapping the CYP2R1 rs10741657 AG genotype specifically to quantitative thyroid peroxidase (TPO) or thyroglobulin (Tg) antibody levels remains limited. However, an indirect pathway linking genetically reduced vitamin D availability to altered immune tolerance and elevated thyroid autoantibody activity is highly plausible.
Bottom line
- Bottom line: The CYP2R1 rs10741657 AG genotype and low baseline vitamin D status directly impair hepatic 25-hydroxylase activity, leading to lower circulating 25(OH)D. This deficit compromises local immune tolerance mechanisms, which plausibly influences autoimmune thyroid antibody activity, though direct quantitative genetic-correlation data are still emerging.
References
- rs10741657 (CYP2R1) — genewizard.net — genewizard.net
- Effects of CYP2R1 gene variants on vitamin D levels and status — pubmed.ncbi.nlm.nih.gov
- Common Variants in CYP2R1 and GC Genes Predict Vitamin D ... — pmc.ncbi.nlm.nih.gov
- Vitamin D | CYP2R1 (rs10741657) — plexusdx.com
- The CYP2R1 Enzyme: Structure, Function, Enzymatic Properties and Genetic Polymorphism. — journals.library.ualberta.ca
- Review Effects of CYP2R1 gene variants on vitamin D levels and status: A systematic review and meta-analysis — sciencedirect.com
- New Variants of the Cytochrome P450 2R1 (CYP2R1) Gene in Individuals with Severe Vitamin D-Activating Enzyme 25(OH)D Deficiency — mdpi.com
- CYP2R1 (vitamin D 25‐hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans — onlinelibrary.wiley.com
See a full patient report verified like this
Book a walkthrough